In silico preliminary evaluation of bioactive compounds from five Unani drugs as potential SARS-CoV-2 inhibitors: IN SILICO EVIDENCE OF FIVE UNANI DRUGS AGAINST SARS-COV-2. IJTK [Internet]. 2024 Mar. 18 [cited 2026 Jun. 10];23(3):247-61. Available from: https://or.niscpr.res.in/index.php/IJTK/article/view/1412